Francis J. Bullock
Corporate Officer/Principal chez Puretech Health LLC
Profil
Dr. Bullock has served as the Senior Vice President, Research Operations at Schering Plough Research Institute, from 1981-1993, where he took over 30 new chemical entities into clinical development in many therapeutic areas including antibacterials, antifungals, antivirals, cardiovasculars, pain, inflammation, allergy, and cancer.
His track record includes five successful registrations including Claritin and Intron (Interferon Alpha 2b) that generated cumulative peak sales of around $3.5B annually.
Dr. Bullock serves on the board of directors for TSI Corporation, Genzyme Transgenics Corporation, Array Biopharma, and ARCA Discovery.
Postes actifs de Francis J. Bullock
| Sociétés | Poste | Début |
|---|---|---|
Puretech Health LLC
 Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Corporate Officer/Principal | 29/12/2010 |
Anciens postes connus de Francis J. Bullock
| Sociétés | Poste | Fin |
|---|---|---|
| ARRAY TECHNOLOGIES, INC. | Directeur/Membre du Conseil | 24/10/2012 |
| REVO BIOLOGICS INC | Directeur/Membre du Conseil | 06/12/2010 |
| ARCA BIOPHARMA, INC. | Directeur/Membre du Conseil | 29/01/2009 |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Directeur Technique/Scientifique/R&D | 01/08/1993 |
| Atherex Corp. | Directeur/Membre du Conseil | - |
Formation de Francis J. Bullock
| Harvard University | Doctorate Degree |
| Massachusetts College of Pharmacy & Health Science | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ARCA BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Finance |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Health Technology |
| Atherex Corp. | |
rEVO Biologics, Inc.
 rEVO Biologics, Inc. BiotechnologyHealth Technology rEVO Biologics, Inc. engages in the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. Its products include ATryn, which prevents blood clots during and after surgery and childbirth for patients with hereditary antithrombin deficiency. The company was founded in February 1993 and is headquartered in Framingham, MA. | Health Technology |
